U.S. Beverage Stock News

Why Evercore (EVR) is on investors’ radar today Evercore (EVR) has drawn fresh attention after a period of mixed share performance, with a recent 0.4% daily gain that contrasts with weaker moves over the past week, month, and past 3 months. See our latest analysis for Evercore. That 0.4% 1 day share price gain comes after a tougher spell, with a 7.2% 7 day share price decline and a 23.6% year to date share price decline, even though the 1 year total shareholder return is 35.1% and the 3 year...

Wynn Resorts has resumed construction on its US$5.10 billion Wynn Al Marjan Island integrated resort in Ras Al Khaimah, UAE, after a brief security-related pause, while maintaining close coordination with US and UAE authorities to safeguard employees and operations. This restart reinforces Wynn’s push into the Middle East through a 40% stake in the project, marking the region’s first large-scale casino resort and expanding its luxury hospitality footprint beyond existing US and Asia...

If you are wondering whether Enova International at around US$134.11 is still offering value or already pricing in a lot of optimism, you are asking the right question for this stock. The share price has seen a 2.5% decline over the last 7 days and a 10.1% decline over the last 30 days, although the 1 year return sits at 44.8% and the 3 year return is 220.5%, with 5 year returns at 266.4%. Recent coverage of Enova International has focused on its position within the diversified financials...

Earlier this month, Surgery Partners, Inc. reported 2025 results showing higher sales of US$885.0 million for the fourth quarter and US$3.31 billion for the year but continuing net losses, issued softer 2026 revenue guidance of US$3.35 billion to US$3.45 billion, launched a new US$200.0 million share repurchase program, and appointed veteran health system executive Lloyd Dean as an independent director. These developments, alongside pressure from activist investor Ortelius Advisors pushing...

Corvus Pharmaceuticals stock moves after recent performance swings Corvus Pharmaceuticals (CRVS) has been drawing fresh attention as its share price reflected sharp recent moves, including a 4.3% decline over the past day and a month return that is roughly 17.9% lower. See our latest analysis for Corvus Pharmaceuticals. Even with the latest 4.3% one day share price decline and a softer 30 day share price return of 17.9%, Corvus Pharmaceuticals still shows strong upward momentum, with a 90 day...

Winmark Corp recently passed the Caviar Cruise quality investing screen, which highlights companies with durable competitive strengths, high profitability, and solid financial health. This recognition emphasizes Winmark’s franchise-based model, where high returns on invested capital and strong cash flow conversion underpin its operational quality. We’ll now examine how Winmark’s very high return on invested capital shapes the company’s investment narrative following these quality-focused...

Why Verisk’s new buyback is drawing fresh attention Verisk Analytics (VRSK) has come back into focus after launching a $1.5b accelerated share repurchase program and stepping up investor outreach through an Analyst and Investor Day plus back to back conference appearances. See our latest analysis for Verisk Analytics. The 1 month share price return of 11.04% and 1 day move of 1.61% to US$201.22 sit against a 1 year total shareholder return of 29.73% decline. The recent buyback announcement...

Amalgamated Financial (AMAL) is back in focus after reporting fourth quarter 2025 earnings, with revenue of $87.91 million that topped forecasts, alongside continued insider share sales by a senior executive. See our latest analysis for Amalgamated Financial. The latest quarterly update and ongoing insider selling come against a mixed price backdrop, with a 1 day share price return of 0.37% and a 30 day share price decline of 7.95%, while the 90 day share price return of 18.10% and 1 year...

Turning Point Brands recently reported fourth-quarter 2025 sales of US$121.01 million and full-year sales of US$463.06 million, alongside 2026 Modern Oral gross revenue guidance of US$220 million to US$240 million and net revenue guidance of US$180 million to US$190 million. At the same time, FRE® Nicotine Pouches’ new NASCAR Cup Series partnership with 23XI Racing and driver Riley Herbst signals a push to broaden brand reach and retail penetration, particularly in the Las Vegas...

Earlier this week, Madison Square Garden Sports Corp. and Blueair announced a partnership making Blueair the Official Air Care Partner of the New York Knicks, integrating its air wellness technology into the Knicks’ training center and prominent digital and in-arena platforms. Beyond branding, the collaboration underscores how MSG Sports continues to monetize the Knicks’ profile through specialized sponsorships that link performance, health, and fan engagement across multiple channels. Next,...

Earlier this month, Silicon Motion Technology Corporation launched the SM8008, a PCIe Gen5 x4 NVMe enterprise SSD controller built on TSMC 6nm, targeting power-efficient data center boot drives with up to 14GB/s throughput, over 2.3 million 4K random IOPS, and extensive enterprise-grade security features across multiple server form factors. This move highlights Silicon Motion’s push to carve out dedicated boot storage as a distinct enterprise segment, aligning its controller roadmap with...

In early March 2026, YETI Holdings participated in back-to-back consumer and retail conferences hosted by Citi and Bank of America in the Miami area, outlining its outlook to institutional investors. Soon after these appearances, Morgan Stanley raised fresh concerns about YETI’s weaker 2026 guidance and earnings trajectory, sharpening investor focus on the company’s medium-term performance risks. With Morgan Stanley’s cautious commentary on YETI’s 2026 outlook now on the table, we’ll...

In early March 2026, FirstEnergy faced a severe windstorm across Ohio, Pennsylvania, West Virginia and Maryland, initially cutting power to about 655,400 customers before restoring service to nearly 478,000 within one day as crews and external teams worked continuously. The scale and speed of this restoration effort highlight how FirstEnergy’s operational readiness and grid resilience practices are tested in real-world conditions that matter to both customers and investors. Now we’ll examine...

Recently, Thermon Group Holdings reported strong fiscal third-quarter results, including about US$147 million in revenue and a 14% rise in new orders to US$158.2 million, leading management to raise full-year 2026 revenue guidance to US$516–526 million and adjusted EBITDA guidance to US$114–120 million. At the same time, institutional investor Clifford Capital Partners expanded its position by acquiring 414,006 shares, a move that underscores growing confidence in Thermon’s industrial...

If you are wondering whether Herc Holdings' current share price reflects its true worth, this article will walk through what the numbers are actually saying about value. The stock recently closed at US$108.91, with returns of 9.1% over 3 years and 18.8% over 5 years. More recent periods have been weaker, with a 7 day return of 9.3%, 30 day return of 37.1%, year to date return of 28.5% and 1 year return of 14.0%. Recent coverage has focused on Herc Holdings as a US equipment rental company...

In recent days, Sunoco LP has drawn attention ahead of its past earnings release, as analysts projected year-over-year improvements in earnings per share and revenue while estimate revisions signaled shifting expectations. At the same time, research firms have offered mixed signals, with an 'Overweight' rating from Wells Fargo contrasting with a Zacks Rank of #4 (Sell), highlighting differing views on Sunoco’s near-term prospects. We’ll now examine how this mix of upbeat earnings...

If you are trying to figure out whether Medpace Holdings at around US$450 per share is still good value, you are not alone. This article is written with that question front and center. The stock has had a mixed run recently, with a 4.3% decline over the last 7 days, a 5.2% gain over 30 days, a 21.1% decline year to date, yet a 38.6% return over 1 year and a 156.4% return over 3 years. These moves have kept Medpace on many investors' watchlists, with attention on how its contract research...

In early March 2026, Broadridge Financial Solutions announced several moves, including integrating Crypto.com into its global NYFIX order-routing network, enhancing ProxyVote with pass-through voting for Vanguard investors, appointing a new Chief Growth and Strategy Officer, and affirming a quarterly dividend of US$0.975 per share payable on April 8, 2026. Together, these steps highlight how Broadridge is linking traditional market plumbing with digital assets, expanding shareholder voting...

Earlier this week, Kyivstar Group Ltd. reported its full-year 2025 results, with sales rising to US$1,157 million from US$919 million, even as net income fell to US$124 million from US$283 million and basic EPS from continuing operations declined to US$0.57 from US$1.37. The company also issued 2026 guidance calling for USD revenue growth of 8%–11%, underlining management’s confidence in further expanding its fast-growing digital and connectivity ecosystem despite a volatile operating...

In recent days, JPMorgan Chase restricted lending to private credit providers after marking down several loans fuelling growing concern about stress in the private credit market.

In March 2026, Texas Capital Bancshares announced it will redeem all US$375,000,000 of its 4.000% fixed-to-fixed rate subordinated notes due 2031 on May 6, 2026, at par plus accrued and unpaid interest, under its existing indenture with U.S. Bank Trust Company as trustee. This move, alongside recent insider share purchases and a rebound in quarterly profitability, points to management confidence in the bank’s balance sheet and earnings profile. We’ll now examine how the planned subordinated...

In recent days, Intuitive Surgical reported that a targeted phishing-related cybersecurity incident allowed an unauthorized third party to access certain internal IT business applications containing limited customer and employee data, while confirming that its da Vinci and Ion surgical platforms remained secure and fully operational. The incident highlights how cybersecurity and data governance have become material operational considerations even for MedTech companies whose core value...

Why Sunstone Hotel Investors Is Back on Investors’ Radar Sunstone Hotel Investors (SHO) is drawing fresh attention after a stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year, and 5 years. At the same time, the lodging focused real estate investment trust reports annual revenue of US$960.1 million and net income of US$8.2 million. These figures give investors a starting point for assessing how the current share price...

Akso Health Group recently reported revenue growth of 75.6%, coinciding with its shares reaching a fresh 52-week high in past trading. This combination of rapid top-line expansion and a record-year price level highlights how operational momentum can reshape perceptions of the company’s prospects. Next, we will examine how this rapid revenue growth influences Akso Health Group’s investment narrative in light of its recent share price gains. We've uncovered the 14 dividend fortresses yielding...